Evidence map›Paper›PMID 37132279›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2023

Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease.

Salvatore Rudilosso, Michael S Stringer, Michael Thrippleton, Francesca Chappell, Gordon W Blair, Daniela Jaime Garcia, Fergus Doubal, Iona Hamilton, Esther Janssen, Anna Kopczak and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Roles of Microglia in Cerebral Small Vessel Disease.CNS neuroscience & therapeutics · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 5 countries.

Salvatore RudilossoComprehensive Stroke Center, Department of Neuroscience, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.ORCID 0000-0002-8775-6884
Michael S StringerCentre for Clinical Brain Sciences, UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-3811-4439
Michael ThrippletonCentre for Clinical Brain Sciences, UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.
Francesca ChappellCentre for Clinical Brain Sciences, UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.
Gordon W BlairCentre for Clinical Brain Sciences, UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.
Daniela Jaime GarciaCentre for Clinical Brain Sciences, UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.
Fergus DoubalCentre for Clinical Brain Sciences, UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.
Iona HamiltonCentre for Clinical Brain Sciences, UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.
Esther JanssenDepartment of Neurology, Radboud University Medical Centre (Radboudumc), Nijmegen, The Netherlands.
Anna KopczakInstitute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-5037-2342
Michael IngrischDepartment of Radiology, University Hospital, LMU Munich, Munich, Germany.
Danielle KerkhofsDepartment of Neurology and School for Cardiovascular Diseases (CARIM), Maastricht University Medical Center+, Maastricht, The Netherlands.
Walter H BackesDepartment of Radiology & Nuclear Medicine, Schools for Mental Health & Neuroscience and School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, Netherlands.
Julie StaalsDepartment of Neurology and School for Cardiovascular Diseases (CARIM), Maastricht University Medical Center+, Maastricht, The Netherlands.
Marco DueringInstitute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-2302-3136
Martin DichgansInstitute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.
Joanna M WardlawCentre for Clinical Brain Sciences, UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-9812-6642
SVDs@target consortium
UK Dementia Research Institute · GBLMU Klinikum · DEMaastricht University · NLConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESGerman Center for Neurodegenerative Diseases · DEMaastricht University Medical Centre · NLRadboud University Nijmegen · NLUniversity of Basel · CH

Funding

Chief Scientist Office ETM/326Medical Research CouncilThe Dunhill Medical Trust R380R/1114Wellcome TrustWellcome Trust 104916/Z/14/Z
6 · The paper itself

Abstract

Blood-brain barrier (BBB) is known to be impaired in cerebral small vessel disease (SVD), and is measurable by dynamic-contrast enhancement (DCE)-MRI. In a cohort of 69 patients (42 sporadic, 27 monogenic SVD), who underwent 3T MRI, including DCE and cerebrovascular reactivity (CVR) sequences, we assessed the relationship of BBB-leakage hotspots to SVD lesions (lacunes, white matter hyperintensities (WMH), and microbleeds). We defined as hotspots the regions with permeability surface area product highest decile on DCE-derived maps within the white matter. We assessed factors associated with the presence and number of hotspots corresponding to SVD lesions in multivariable regression models adjusted for age, WMH volume, number of lacunes, and SVD type. We identified hotspots at lacune edges in 29/46 (63%) patients with lacunes, within WMH in 26/60 (43%) and at the WMH edges in 34/60 (57%) patients with WMH, and microbleed edges in 4/11 (36%) patients with microbleeds. In adjusted analysis, lower WMH-CVR was associated with presence and number of hotspots at lacune edges, and higher WMH volume with hotspots within WMH and at WMH edges, independently of the SVD type. In conclusion, SVD lesions frequently collocate with high BBB-leakage in patients with sporadic and monogenic forms of SVD.

Indexed as

Cerebral Small Vessel DiseasesWhite MatterBlood-Brain BarrierCerebral HemorrhageHumansMagnetic Resonance ImagingBlood-brain barriercerebral small vessel diseasedynamic-contrast enhanced imaginglacunarwhite matter hyperintensities

Identifiers

PMID37132279
PMCPMC10414006
OpenAlexW4367834238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.